The prevalence of multiple endocrine neoplasia 2 (MEN2) which is subdivided into MEN2A and MEN2B is estimated to account for 1–3% of all thyroid malignant tumors [1,2]. The gene discussed is RET; the disease is multiple endocrine neoplasia.